The broader economic impact of vaccination: reviewing and appraising the strength of evidence
- PMID: 26335923
- PMCID: PMC4558933
- DOI: 10.1186/s12916-015-0446-9
The broader economic impact of vaccination: reviewing and appraising the strength of evidence
Abstract
Background: Microeconomic evaluations of public health programmes such as immunisation typically only consider direct health benefits and medical cost savings. Broader economic benefits around childhood development, household behaviour, and macro-economic indicators are increasingly important, but the evidence linking immunization to such benefits is unclear.
Methods: A conceptual framework of pathways between immunisation and its proposed broader economic benefits was developed through expert consultation. Relevant articles were obtained from previous reviews, snowballing, and expert consultation. Articles were associated with one of the pathways and quality assessed using modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria.
Results: We found 20 studies directly relevant to one or more pathways. Evidence of moderate quality from experimental and observational studies was found for benefits due to immunisation in improved childhood physical development, educational outcomes, and equity in distribution of health gains. Only modelling evidence or evidence outside the immunization field supports extrapolating these benefits to household economic behaviour and macro-economic indicators.
Conclusion: Innovative use of experimental and observational study designs is needed to fill evidence gaps around key pathways between immunisation and many of its proposed economic benefits.
Figures
Similar articles
-
Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.BMC Public Health. 2015 Apr 10;15:356. doi: 10.1186/s12889-015-1638-0. BMC Public Health. 2015. PMID: 25881178 Free PMC article.
-
Health economic research on vaccinations and immunisation practices--an introductory primer.Vaccine. 2005 Mar 18;23(17-18):2095-103. doi: 10.1016/j.vaccine.2005.01.064. Vaccine. 2005. PMID: 15755578 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Assessing the economic benefits of vaccines based on the health investment life course framework: a review of a broader approach to evaluate malaria vaccination.Vaccine. 2015 Mar 24;33(13):1527-40. doi: 10.1016/j.vaccine.2015.01.059. Epub 2015 Feb 18. Vaccine. 2015. PMID: 25701316 Review.
-
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591. Health Technol Assess. 2024. PMID: 38938110 Free PMC article.
Cited by
-
Acceptance and application of a broad population health perspective when evaluating vaccine.Vaccine. 2022 May 26;40(24):3395-3401. doi: 10.1016/j.vaccine.2022.04.009. Epub 2022 May 5. Vaccine. 2022. PMID: 35525728 Free PMC article.
-
On spillovers in economic evaluations: definition, mapping review and research agenda.Eur J Health Econ. 2024 Sep;25(7):1239-1260. doi: 10.1007/s10198-023-01658-8. Epub 2024 Jan 23. Eur J Health Econ. 2024. PMID: 38261132 Free PMC article. Review.
-
Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare.Infect Dis Ther. 2023 Dec;12(12):2649-2663. doi: 10.1007/s40121-023-00888-w. Epub 2023 Dec 4. Infect Dis Ther. 2023. PMID: 38048020 Free PMC article.
-
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.Hum Vaccin Immunother. 2022 Dec 30;18(7):2135916. doi: 10.1080/21645515.2022.2135916. Epub 2022 Dec 12. Hum Vaccin Immunother. 2022. PMID: 36507685 Free PMC article.
-
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries.Appl Health Econ Health Policy. 2022 May;20(3):395-404. doi: 10.1007/s40258-021-00711-y. Epub 2022 Jan 10. Appl Health Econ Health Policy. 2022. PMID: 35001292 Free PMC article. Review.
References
-
- Institute for Health Metrics and Evaluation. Development assistance for health, country and regional recipient level database 1990–2010. http://ghdx.healthdata.org/record/development-assistance-health-country-.... Accessed on 20 August 2015.
-
- Bloom DE, Canning D, Jamison DT. Health, wealth, and welfare. Finance Dev. 2004;41:10–5.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
